Issue link: https://viewer.e-digitaledition.com/i/37373
SPECIAL FEATURE “The most important factor in a good outcome after surgery for prostate cancer is the experience of the surgeon,” says Eric A. Klein, M.D., Chair of the Glickman Urological & Kidney Institute. “Cleveland Clinic’s urological surgeons are among the most experienced in the world, which greatly benefi ts our patients because it translates into an increased like- lihood of a cure and return of continence and potency.” First-Class Care for Colorectal Cancer The Digestive Disease Institute (DDI) at Eric A. Klein, M.D. Cleveland Clinic is ranked second in the nation and the highest in Ohio, according to U.S. News & World Report. Physicians at Cleveland Clinic perform one of the highest volumes of colorectal surgery in the United States and were the fi rst in the world to offer single-incision colectomy and proctolectomy. BY THE NUMBERS U.S. News & World Report has verifi ed Cleveland Clinic’s high level of exceptional care by recognizing the hospital in its Best Hospitals list, which ranks the top 50 hospitals in the United States, organized by specialty. Currently, Cleveland Clinic ranks No. 9 in cancer, No. 2 in urology, No. 3 in digestive, No. 4 in gynecology and No. 6 in neurology and neurosurgery. free-fl ap reconstruction allows physicians to leave the abdominal muscle intact. Cleveland Clinic is one of only a few centers in the world that provides the DIEP free-fl ap reconstruction technique. Improving Outcomes for Cancers of the Prostate and Kidney Offering a wide array of services for urological and kidney dis- eases, including cancers of the bladder, kidney, prostate and testes, the Glickman Urological & Kidney Institute (GUKI) — through partnership with the Taussig Cancer Institute — emphasizes a personalized approach to care, examining all medical and surgical options to provide patients with an individualized treatment plan that ensures an optimal outcome. The team of GUKI physicians treating patients is an experienced group of medical professionals trained in the most up-to-date techniques. Offering minimally invasive, virtually scarless uro- logical procedures, Cleveland Clinic surgeons were the fi rst in the United States to utilize the single-port technique for treatment of prostate cancer. 16 | Central New York MD NEWS MDNEWS.COM “Colorectal surgery is clearly changing,” says Feza H. Remzi, M.D., Chair of Colorectal Surgery at the Digestive Disease Institute. “Over the past decade, we have led the world in laparoscopic colorectal surgery. We have one of the highest volumes of any single center in the nation. The future is to push the envelope — smaller incisions, fewer ports and different extraction sites.” The team of DDI medical providers treating patients includes colon and rectal cancer specialists, colorectal surgeons and gastroenterologists, as well as medical and radiation oncologists and genetic counselors from the Taussig Cancer Institute. Together, these physicians collaborate to develop individualized care plans that — depending on the patient’s age and cancer stage — may include surgery, chemotherapy and radiation therapy. A Leader in Research Cleveland Clinic is a leader in advancing the fi eld of oncology through laboratory, clinical and translational research and is involved in more than 300 clinical trials. Helping revolutionize cancer treatment, Cleveland Clinic researchers have been the fi rst to identify molecules with anti-tumor effects and have been instrumental in developing new modalities, including new cancer therapies. “Cleveland Clinic is part of the Case Comprehensive Cancer Center, which means that we have linkages with the National Cancer Institute to allow for access to drug discovery and to drugs that are in the early stages of development,” says Dr. Bolwell. “We are very proud of our physician-scientists, many of whom are world-renowned leaders in their area of expertise. One example is our leadership in the American Society of Hematology [ASH], as we are one of a handful of cancer centers that annually present two scientifi c symposia

